Plexr vs CO2 Laser: Plasma Soft Surgery and Fractional Resurfacing Compared

The core distinction is geometry, not power: CO2 lasers resurface an area of skin by ablating it in a controlled thermal pattern; Plexr Plus sublimates individual points of tissue at the surface, without a beam and without treating the skin around them, which is what makes it usable millimetres from the lash line.

The short version. Plexr Plus is an FDA-cleared plasma soft surgery device for precise focal work: eyelid laxity, non-surgical blepharoplasty, small lesions, focal tissue contraction. CO2 laser remodels large fields — significant photodamage, atrophic acne scarring, textural change across a full face. In periorbital practice they are frequently sequenced rather than chosen between. For the broader category overview, see our companion article on plasma pen vs laser.

Two Different Instruments for Two Different Jobs

How Plexr Plus works

The tip never touches skin. It ionises the atmospheric gas in the gap between tip and tissue, and the resulting plasma arc sublimates a microscopic point of epidermis — solid straight to vapour — leaving a small carbon crust. The literature calls this plasma exeresis. There is no beam and no optical penetration to control.

The energy is intense but brief and shallow. Thermal imaging during plasma treatment of benign facial lesions recorded a mean skin surface temperature of 290.3°C during irradiation, falling to 90.6°C immediately afterwards (Scarano et al., Aesthetic Plast Surg, 2020, DOI). That steep drop is the point: energy is spent at the surface rather than propagated beneath it.

A pilot study imaged upper eyelid skin with reflectance confocal microscopy after three plasma exeresis sessions. Dermatochalasis improved by a mean of 2.6 ratings on the facial laxity rating scale, and collagen was classified as long straight fibres in every case, with no serious adverse events (Rossi et al., Dermatol Surg, 2018, DOI).

How CO2 laser resurfacing works

A CO2 laser emits at 10,600 nm, a wavelength absorbed avidly by water. Because skin is mostly water, the beam vaporises tissue to a controlled depth and leaves a rim of residual thermal injury beneath, which drives the collagen response. Fully ablative resurfacing removes the epidermis confluently across the field. Fractional CO2 delivers columns of ablation with untreated skin standing between them, so intact reservoirs re-epithelialise the treated ones and recovery is faster.

Ablative fractional resurfacing produces significantly greater improvement in skin laxity and textural abnormality than non-ablative fractional treatment, and greater reduction in acne scarring and skin redundancy (Tierney et al., Dermatol Surg, 2009, DOI). A multicentre study documented fractional ablative CO2 across rhytides, photoaging, scars and striae in one modality (Alexiades-Armenakas et al., J Drugs Dermatol, 2011, PubMed).

Where CO2 Is Clearly the Right Instrument

Atrophic acne scarring. A randomised study of 40 patients assigned subcision plus fractional CO2 or subcision plus polydioxanone screw threads. The CO2 arm showed significantly greater reduction in scar severity and depth (p = 0.022) and higher satisfaction, though the thread arm recovered faster (Abdo et al., Arch Dermatol Res, 2025, DOI). That trade is the comparison in miniature: more remodelling costs more recovery.

Diffuse photodamage and textural remodelling. When the problem covers a field, you need a modality that treats a field. A systematic review of 1,093 patients found adverse events in 9.7 percent overall, with ablative therapies reporting a lower rate than non-ablative ones (8.28 versus 12.2 percent) and hypertrophic scarring in 0.046 percent (Mirza et al., Dermatol Ther, 2020, DOI). Our CAT resurfacing service sits in this same field-treatment category, covered in our article on CAT resurfacing for skin rejuvenation.

The Periorbital and Eyelid Case

Eyelid skin is the thinnest on the body, sits directly over the globe, and leaves a small margin for error on depth. It is also where plasma soft surgery is used most: in 710 consecutive plasma exeresis patients, over 33 percent were treated on the upper eyelids and 18 percent on the lower eyelids, with 52.9 percent extremely satisfied (Tsioumas et al., J Clin Aesthet Dermatol, 2021, PubMed).

Fifty-six women with mild to severe dermatochalasis and periorbital wrinkles received plasma exeresis three times at one-month intervals, with significant improvement in dermatochalasis and palpebral laxity against baseline (p < 0.001), corroborated by Reviscometer measurement, and no significant or permanent side effects (Abdollahimajd et al., J Cosmet Dermatol, 2021, DOI).

The depth-control advantage is starkest on discrete lesions. Fifteen patients with 27 xanthelasma palpebrarum lesions were treated with a Plexr plasma exeresis device; after a single session all 27 cleared completely, with no scars, pigmentary alteration or recurrence at 12 months, which the authors attributed to the method allowing control of the depth of tissue destruction (Rubins et al., Acta Dermatovenerol Alp Pannonica Adriat, 2020, PubMed).

None of this means CO2 cannot work periorbitally. A split-face study treated one side with fractional CO2 thirty days before upper blepharoplasty and analysed the excised skin: type I and type III collagen were both significantly higher on the treated side (p < 0.0001) (de Filippi Sartori et al., Aesthet Surg J, 2022, DOI). The real question is whether a focal eyelid concern justifies a field-resurfacing recovery. Reviews of non-surgical blepharoplasty list both as credible options for combined skin excess and elasticity loss, precisely because each has a niche (Miotti et al., World J Clin Cases, 2023, DOI; Theodorelou-Charitou et al., J Plast Reconstr Aesthet Surg, 2021, DOI).

Fitzpatrick IV to VI and Post-Inflammatory Hyperpigmentation

Here the comparison stops being academic. In higher Fitzpatrick types, post-inflammatory hyperpigmentation after ablative laser is not a rare complication but a design constraint. A 2025 study of fractional CO2 for acne scars states it plainly: in darker skin types the high risk of post-inflammatory hyperpigmentation after fractional CO2 remains a significant limitation affecting treatment outcomes — the study existed to test a peel protocol to reduce it (Hang and Lim, J Cosmet Dermatol, 2025, DOI). A broad review of dermatologic laser use reaches the same conclusion and calls for skin-type-specific protocols (Al Timimi et al., Ir J Med Sci, 2025, DOI).

For scale: in 50 patients treated with single-pass CO2, hyperpigmentation occurred in 46 percent and lasted an average of 12.7 weeks (Tanzi and Alster, Dermatol Surg, 2003, DOI). Trials of fractional CO2 in Fitzpatrick III to IV patients were designed around the same concern (Vachiramon et al., Lasers Surg Med, 2016, DOI).

Plasma is not a zero-pigment-risk treatment, and we will not claim it is. Among 45 patients treated with plasma for benign facial lesions, three developed transient post-inflammatory pigmentation peaking at one month and fading spontaneously over two to three months (Scarano et al., 2020, DOI). In a randomised trial against cryotherapy, the most common complication in the plasma arm was erythema (Noorbakhsh et al., Skin Res Technol, 2023, DOI), and in plasma upper eyelid blepharoplasty, Fitzpatrick skin type was significantly associated with satisfaction at 30 days (p = 0.043) (Ferreira et al., J Cosmet Dermatol, 2020, DOI).

The honest summary: both modalities require skin-type-aware planning, but the pigmented area placed at risk scales with the area you treat. For patients in Fitzpatrick IV to VI wanting periorbital treatment, that arithmetic is often decisive.

Healing Course and Honest Downtime

Plexr Plus, day by day

Days 0 to 2. Tiny dark carbon crusts appear at each treated point almost immediately, and swelling around the eyes is usually most obvious on the second morning. Discomfort is modest; a combined plasma and hyaluronic acid protocol recorded a mean pain score of 2.4 out of 10 (Paganelli et al., J Cosmet Dermatol, 2019, DOI).

Days 3 to 7. Crusts separate on their own. Eyelid oedema was the symptom most reported at day 7, and physical appearance was the factor most affecting quality of life in that first week (Ferreira et al., 2020, DOI). This is the socially awkward window; plan for it.

Weeks 2 to 6. Pink new skin fading toward normal tone; itching was the symptom most reported at day 30 in the same study. By weeks four to six, collagen reorganisation is visible on confocal imaging (Rossi et al., 2018, DOI).

CO2 laser, day by day

Days 0 to 6. Open, weeping, occlusive-ointment recovery. Mean time to re-epithelialisation after single-pass CO2 was 5.5 days (Tanzi and Alster, 2003, DOI); in a recent fractional CO2 acne scar cohort it was day 6.2 to 6.4 (Hang and Lim, 2025, DOI).

Weeks 1 to 3. After periorbital ablative resurfacing, oedema, erythema and discoloration were reported in almost all patients, lasting two to three weeks and resolving without intervention (Guida et al., Photomed Laser Surg, 2018, DOI).

Weeks 3 to 8. Erythema was observed in all patients after single-pass CO2, averaging 4.5 weeks (Tanzi and Alster, 2003, DOI). Coverable with makeup, but present.

Plexr's downtime is concentrated, visible and short. CO2's is longer and includes a genuine wound-care phase.

Sessions, Timelines and Results Longevity

Periorbital plasma protocols cluster around three sessions at monthly intervals (Abdollahimajd et al., 2021, DOI; Rossi et al., 2018, DOI). Discrete targets resolve in fewer: 27 of 27 xanthelasma cleared after one session (Rubins et al., 2020, PubMed), and keloids were treated over two to three sessions, total Vancouver Scar Scale falling from 8.96 to 2.00 (Delavar et al., J Lasers Med Sci, 2023, DOI). Fractional CO2 acne scar protocols commonly run four sessions at four-week intervals (Mohamed et al., Photodermatol Photoimmunol Photomed, 2021, DOI).

Neither treatment stops ageing, and anyone quoting a duration should be asked which study it came from. What is documented is that improvement continues after visible healing ends: periorbital rhytid improvement measured 23 percent at one month and 43.67 percent at six months in the split-face CO2 study (de Filippi Sartori et al., 2022, DOI). On the plasma side, treated xanthelasma showed no recurrence at 12 months (Rubins et al., 2020, PubMed), and a larger atmospheric plasma series followed patients out to 11 years (Scarano et al., J Biol Regul Homeost Agents, 2021, DOI).

One finding deserves quoting against our own interest. In the plasma upper eyelid study, satisfaction was highest at day 7 (p = 0.038) and the authors noted decreased expectation with results over the postoperative period (Ferreira et al., 2020, DOI). Sixteen patients is small, and it is the least flattering result in this literature — and exactly what should shape a consultation. Our page on Plexr Plus protocols describes how we structure a course.

When the Two Are Sequenced Rather Than Chosen Between

The split-face study above deliberately used fractional CO2 thirty days before upper blepharoplasty on one side, then treated the other side immediately after surgery — laser and surgical excision as one staged plan rather than alternatives (de Filippi Sartori et al., 2022, DOI). Plasma exeresis has likewise been combined with non-cross-linked hyaluronic acid for neck laxity, scoring 1 or 2 on the Global Aesthetic Improvement Scale in 90 percent of cases (Paganelli et al., 2019, DOI).

A common real-world sequence is field resurfacing for diffuse texture and photodamage, then focal plasma work on the eyelid laxity resurfacing was never going to lift. Order and interval are clinical decisions; we found no published trial establishing a general schedule for combining these two modalities that we would cite as a protocol.

Cost Framing

Cost tracks area treated, session count and recovery support, which is why a focal plasma course and a full-face CO2 course are not comparable line items. Full-face resurfacing is generally the larger investment per event; a focal plasma course is smaller per session but is usually a course rather than one visit. We do not publish per-session prices here, because the plan and therefore the cost is confirmed once your skin has been examined. Our article on Plexr plasma pen treatment cost covers what drives the number.

How the Choice Is Made at Arbour

Is the concern focal or diffuse? Eyelid hooding, a specific lesion, a defined band of laxity: focal. Full-face photodamage or widespread atrophic scarring: diffuse. This question resolves most cases.

What is your Fitzpatrick type and pigmentation history? For types IV to VI the published hyperpigmentation risk after ablative resurfacing is a planning input, not a footnote (Hang and Lim, 2025, DOI).

What recovery can you accommodate? A visible week versus a wound-care week plus a month of erythema are different commitments.

What is the longer arc? Our skin longevity approach treats any one treatment as a component rather than an endpoint, and plasma soft surgery sits inside that. Nothing on this page is a diagnosis or a recommendation for any individual.

Frequently Asked Questions

Is Plexr Plus FDA-cleared?

Yes. Plexr Plus is FDA-cleared.

Can CO2 laser be used on my eyelids, or is that only Plexr?

CO2 is used periorbitally, with histochemical evidence of increased type I and type III collagen in treated eyelid skin (de Filippi Sartori et al., 2022, DOI). The practical question is whether a focal eyelid concern warrants a field-resurfacing recovery when a point treatment reaches the same target with a shorter one.

I have deeper skin. Which is safer for me?

Skin type is assessed in person, but the literature is direct that post-inflammatory hyperpigmentation after fractional CO2 remains a significant limitation in darker skin types (Hang and Lim, 2025, DOI; Al Timimi et al., 2025, DOI). Plasma is not risk-free either, but treating points rather than a field leaves far less surface area at risk (Scarano et al., 2020, DOI).

Will Plexr fix my acne scars the way a CO2 laser would?

For widespread atrophic acne scarring, fractional CO2 has the stronger comparative evidence (Abdo et al., 2025, DOI). Plasma exeresis has published results on discrete scars, including keloids (Delavar et al., 2023, DOI). Different scar problems, different instruments.

How long will I look like I had something done?

With plasma, crusting and swelling concentrate in the first week (Ferreira et al., 2020, DOI). With CO2, re-epithelialisation takes roughly five to six days and erythema averaged 4.5 weeks in one series, present in every patient (Tanzi and Alster, 2003, DOI).

Can I have both, and how many sessions will I need?

Frequently both, yes — periorbital practice already combines resurfacing with focal and surgical techniques as staged plans (Miotti et al., 2023, DOI). Periorbital plasma studies used three sessions at monthly intervals (Abdollahimajd et al., 2021, DOI), focal lesions have cleared in one (Rubins et al., 2020, PubMed), and fractional CO2 acne scar protocols commonly run four sessions at four-week intervals (Mohamed et al., 2021, DOI). Your number is set after examination, not before.

Plexr Plus and Resurfacing Consultations in Ann Arbor

At Arbour Longevity we examine skin in person first, because whether your concern is focal or diffuse is not something a web page can determine. We offer plasma soft surgery with Plexr Plus, structured Plexr Plus protocols and CAT resurfacing, within a broader skin longevity plan. See also Plexr soft surgery in Ann Arbor and PlexrPlus plasma resurfacing and the non-surgical facelift.

Gandhi Bhattarai, FNP-BC, PMHNP-BC, Anti-Aging/Functional Medicine BC is a triple board certified nurse practitioner. We are at 2217 Packard St #15, Eastover Professional Center, Ann Arbor, MI 48104, open Thursday through Monday, 10am to 7pm, closed Tuesday and Wednesday. Parking is free and directly outside, with no meters and no structure. Suite 15 is down a flight of stairs; if stairs are difficult for you, please call (734) 436-3357 before visiting so we can help. Call (734) 436-3357 or book your first visit. The first visit is $35, applied toward your treatment plan.

Clinical information on this page is drawn from articles retrieved from PubMed and is provided for education. It is not medical advice, not a diagnosis, and not a promise of any individual result.